| Literature DB >> 1352246 |
M Beneke1, W Wingender, R Horstmann, I Konrad-Dalhoff, H Weber, J Kuhlmann, B H Schmidt.
Abstract
The neuroendocrine effects (changes in plasma CRF, ACTH and cortisol) of single and multiple (t.d.s. for 2 days) doses of ipsapirone (BAY Q 7821) 5 and 10 mg have been investigated in 6 healthy male volunteers. The study followed a balanced complete block, placebo-controlled and double blind design with two baseline phases (pre and post-treatment). Volunteers were investigated on identical days during 5 successive weeks. The results do not show a specific effect of ipsapirone on the hypothalamic-pituitary-adrenal axis when doses in the range of 5-30 mg per day were given.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1352246 DOI: 10.1007/bf00278478
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 2.953